ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 29, 2004

NCI-Approved Clinical Trials

October 29, 2004

NCI-Approved Clinical Trials

March 31, 2006

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977

In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist

November 7, 1975